Profiles of brain metastases: Prioritization of therapeutic targets
Sherise D. Ferguson(The University of Texas MD Anderson Cancer Center), Amy B. Heimberger(Northwestern University), Mustafa Khasraw(Northwestern University), Siyuan Zheng(Third Affiliated Hospital of Guangzhou Medical University), Jeremy Rudnick(Cedars-Sinai Medical Center), Jethro Hu(Cedars-Sinai Medical Center), Priscilla K. Brastianos(Massachusetts General Hospital), John DeGroot(University of California, San Francisco), Shouhao Zhou(Pennsylvania State University), Zoran Gatalica(Credo Reference (United States)), Michael A. Davies(The University of Texas MD Anderson Cancer Center), John V. Heymach(The University of Texas MD Anderson Cancer Center), Joseph H. McCarty(The University of Texas MD Anderson Cancer Center), David Piccioni(Center for Personalized Cancer Treatment), Waldemar Priebe(The University of Texas MD Anderson Cancer Center), Santosh Kesari(Cancer Institute (WIA)), Nuhad K. Ibrahim(The University of Texas MD Anderson Cancer Center), Sandeep K. Reddy(Indian Institute of Technology Kharagpur), Joanne Xiu(Caris Life Sciences (United States)), David Spetzler(Caris Life Sciences (United States)), Raymond Sawaya(American University of Beirut Medical Center), Jianjun Zhang(The University of Texas MD Anderson Cancer Center), Michael Salacz(The University of Kansas Cancer Center), Barbara O’Brien(The University of Texas MD Anderson Cancer Center), Roeland Verhaak(Broad Institute), Isabella C. Glitza(The University of Texas MD Anderson Cancer Center), Suyun Huang(Virginia Commonwealth University)
Cited by 41
Related Papers
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
|Cell|2016|2.4k
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
|New England Journal of Medicine|2019|1.4k